Full-Time

Account Manager

Triomics

Triomics

51-200 employees

EHR data parsing with oncology LLMs

Compensation Overview

$100k - $140k/yr

New York, NY, USA

Hybrid

Based in New York City, with office attendance and travel to customers required.

Category
Sales & Account Management (1)
Required Skills
Data Visualization
Data Analysis

Get referred to Triomics

See people who can refer or advise you

Requirements
  • Three to six years of account management or customer success experience, ideally at a health technology company where physicians, nurses, and clinical research coordinators are the primary users.
  • Demonstrated ownership of customer relationships end-to-end, from onboarding and implementation through go-live and ongoing success.
  • Strong project management instincts, including the ability to quarterback complex, multi-stakeholder integrations and keep everyone on timeline.
  • High initiative and bias to action, including the ability to identify a gap, build a plan, and execute without waiting to be told.
  • Comfort with data, including diving into analytics, drawing conclusions about adoption and impact, and proposing new reporting, key performance indicators, and dashboards.
  • Excellent communication and credibility with clinical end users.
  • Based in New York City and willing to come to the office and travel to customers, or based in a regional customer hub and willing to travel to the customer base and to New York City periodically.
Responsibilities
  • Serve as the primary point of contact and trusted advisor for accounts from closed-won through go-live and into steady-state.
  • Build deep, durable relationships with customer stakeholders across clinical, research, information technology, and administrative functions.
  • Maintain an up-to-date pulse on account health, including adoption, sentiment, risks, and opportunities to deliver more value.
  • Act as the project manager from the company side of every integration and go-live, coordinating internal teams and customer teams to accelerate timelines.
  • Build and manage integration project plans, milestones, and timelines, and drive accountability on both sides to keep deployments on track.
  • Partner with Forward Deployed Engineers to scope and prioritize customer-specific adjustments to the artificial intelligence pipeline and platform.
  • Partner with Clinical Navigators to design and deliver end-user training that drives adoption among physicians, nurses, and clinical research coordinators.
  • Analyze analytics and reporting to understand user adoption, workflow impact, and real-world technology success.
  • Identify underperforming accounts or unrealized value, develop solutions, and execute them directly or coordinate the appropriate internal team.
  • Propose and help build reporting, key performance indicators, and dashboards to improve understanding of adoption and outcomes.
  • Establish a consistent operating cadence with each account, including business reviews, health checks, and success planning.
  • Surface product feedback and customer needs to Product and Engineering as a structured, prioritized signal.
  • Help build repeatable playbooks, templates, and processes that scale the customer delivery model.
  • Coordinate with Commercial on handoffs, expansion readiness, and renewals.
Desired Qualifications
  • Experience in the clinical research realm, such as supporting clinical trials, working with research coordinators, or familiarity with clinical research operations.
  • Hands-on site experience as a Clinical Research Coordinator or in a similar clinical research role.
  • Experience supporting deeply integrated or technical products, including electronic health record integrations, healthcare information technology, or workflow software.
  • Experience at a rapidly scaling startup and managing multiple accounts or personas simultaneously.
  • Familiarity with oncology care or research workflows.

Triomics uses generative AI to turn unstructured health-record data in oncology into actionable insights. Its OncoLLM analyzes doctor notes, PDFs, and lab results to extract relevant clinical information, with Prism automating patient-to-clinical-trial matching and Harmony curating EHR data for quality reporting and cohort analysis. By integrating with existing EHR systems, it speeds up tasks that used to require hours of manual review and can match patients to trials in minutes with high accuracy. The goal is to reduce manual data review in cancer research and care, accelerate trial enrollment, and support precision oncology for cancer centers, academic medical centers, and health systems.

Company Size

51-200

Company Stage

Series B

Total Funding

$54.2M

Headquarters

New York City, New York

Founded

2020

Get referred to Triomics

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Triomics raised $22 million on May 27, 2026 from Battery Ventures and existing backers.
  • MSK planned Triomics deployment in October 2025, signaling strong enterprise credibility.
  • ASCO 2025 results showed over 30% higher trial accruals using OncoLLM.

What critics are saying

  • Triomics still depends on a few marquee cancer-center deployments and partner validation.
  • Flatiron Health, Tempus, and Epic already own oncology workflow distribution channels.
  • If trial-matching accuracy slips, cancer centers will replace Triomics before 2027 renewals.

What makes Triomics unique

  • OncoLLM is oncology-specific, not generic enterprise AI, and powers PRISM trial matching.
  • Mount Sinai launched Triomics PRISM on January 8, 2026 across its cancer system.
  • Savista and Triomics launched full-stack cancer registry automation on November 4, 2025.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Flexible Work Hours

Meal Benefits

Growth & Insights and Company News

Headcount

6 month growth

-4%

1 year growth

-6%

2 year growth

-7%
TechCrunch
May 27th, 2026
Triomics nabs $22M to bring oncology-specific AI to cancer centers | TechCrunch

The Series B round was led by Battery Ventures.

SVJ Media Ltd.
May 10th, 2024
Triomics Raises $15M for AI Trials

Triomics, a generative AI startup, has secured $15M in Series A funding to enhance cancer clinical trials matching. Founded by Sarim Khan and Hrituraj Singh, the company's OncoLLM platform uses AI to quickly match patients with trials, improving efficiency in cancer care. With this funding from Lightspeed, Nexus Venture Partners, General Catalyst, and Y Combinator, Triomics plans to expand its reach and develop its platform further.

TechCrunch
May 9th, 2024
Triomics raises $15M Series A to automate cancer clinical trials matching | TechCrunch

For cancer patients, medicines administered in clinical trials can help save or extend lives. But despite thousands of trials in the United States each

Intelligence360 News
Mar 6th, 2023
Triomics Has Filed A Notice Of An Exempt Offering Of Securities To Raise $14,135,000.00 In New Equity Investment.

Triomics has filed a notice of an exempt offering of securities to raise $14,135,000.00 in New Equity Investment. Triomics has filed a notice of an exempt offering of securities to raise $14,135,000.00 in New Equity Investment.According to filings with the U.S. Securities and Exchange Commission, Triomics is raising $14,135,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Sarim Khan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.About TriomicsTriomics combines the most advanced clinical trial tracking software with a global network of supersites and partners to deliver rapid, cost-effective, high quality clinical trials that pass even the most rigorous regulatory scrutiny. Triomics Harmony© is powering a host of next-generation applications of healthcare data and systems for advancing clinical research by harnessing the growing maturity of US healthcare on FHIR and addressing its current limitations, enabling us to empower healthcare organizations at any phase of their FHIR adoption journey.To learn more about Triomics, visit http://www.triomics.in/Contact:Sarim Khan, Chief Executive Officer707-227-9112https://www.linkedin.com/in/sarim-khan-triomics/SOURCE: http://www.intelligence360.ioCopyright (c) 2023 SI360 Inc. All rights reserved